2fgu: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2fgu.gif|left|200px]] | [[Image:2fgu.gif|left|200px]] | ||
'''X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.''' | {{Structure | ||
|PDB= 2fgu |SIZE=350|CAPTION= <scene name='initialview01'>2fgu</scene>, resolution 2.00Å | |||
|SITE= | |||
|LIGAND= <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene>, <scene name='pdbligand=QNC:2-CARBONYLQUINOLINE'>QNC</scene> and <scene name='pdbligand=DIQ:2-METHYL-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID'>DIQ</scene> | |||
|ACTIVITY= [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] | |||
|GENE= GAG ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=11676 Human immunodeficiency virus 1]) | |||
}} | |||
'''X-ray crystal structure of HIV-1 Protease T80S variant in complex with the inhibitor saquinavir used to explore the role of invariant Thr80 in HIV-1 protease structure, function, and viral infectivity.''' | |||
==Overview== | ==Overview== | ||
| Line 7: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
2FGU is a [ | 2FGU is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FGU OCA]. | ||
==Reference== | ==Reference== | ||
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity., Foulkes JE, Prabu-Jeyabalan M, Cooper D, Henderson GJ, Harris J, Swanstrom R, Schiffer CA, J Virol. 2006 Jul;80(14):6906-16. PMID:[http:// | Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity., Foulkes JE, Prabu-Jeyabalan M, Cooper D, Henderson GJ, Harris J, Swanstrom R, Schiffer CA, J Virol. 2006 Jul;80(14):6906-16. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16809296 16809296] | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| Line 22: | Line 31: | ||
[[Category: QNC]] | [[Category: QNC]] | ||
[[Category: drug resistance]] | [[Category: drug resistance]] | ||
[[Category: enzyme | [[Category: enzyme kinetic]] | ||
[[Category: hiv protease]] | [[Category: hiv protease]] | ||
[[Category: protein structure]] | [[Category: protein structure]] | ||
[[Category: sequence conservation]] | [[Category: sequence conservation]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 16:52:12 2008'' | ||